• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Sensitivity of Hemoccult test for large bowel cancer in high-risk subjects.

作者信息

Bertario L, Spinelli P, Gennari L, Sala P, Pizzetti P, Severini A, Cozzi G, Bellomi M, Berrino F

机构信息

Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

出版信息

Dig Dis Sci. 1988 May;33(5):609-13. doi: 10.1007/BF01798365.

DOI:10.1007/BF01798365
PMID:3359912
Abstract

From 1979 to 1982, 1233 symptom-free subjects at high risk for colon cancer because of family history and/or personal history of bowel neoplasia (cancer or adenomatous polyp) were examined with a guaiac test (Hemoccult II) for occult blood in stools. The test was positive (H+) in 98 subjects (7.9%). Endoscopy was subsequently performed on 86% of the H+ and on 64% of the H- subjects. Of 20 in invasive cancers found, 15 had been H+ [75.0%; 95% confidence interval (CI), 54.3-91.0%]. Of 96 patients with adenoma(s), 23 were H+ (24%; 95% CI, 16.0-33.0%). However, the sensitivity for adenomas was higher in patients with multiple adenomas or with a single adenoma measuring 2 cm or more in its largest diameter (37.5%; 95% CI, 21.8-54.7%). Of 699 subjects free of neoplastic lesions at endoscopy, 47 had been H+, ie, false positive (6.7%; 95% CI, 5.0-8.7%). Adjusting for differential compliance of H+ and H- subjects to endoscopy, a corrected estimate for sensitivity would be 69% for cancer and 19% for adenomas; the corrected estimate for the false-positive rate would be 5%.

摘要

相似文献

1
Sensitivity of Hemoccult test for large bowel cancer in high-risk subjects.
Dig Dis Sci. 1988 May;33(5):609-13. doi: 10.1007/BF01798365.
2
Reproducibility and diagnostic value of Hemoccult-II test. A colonoscopic evaluation in asymptomatic patients.隐血-II试验的可重复性及诊断价值。无症状患者的结肠镜检查评估。
Scand J Gastroenterol. 1985 Nov;20(9):1073-7. doi: 10.3109/00365528509088874.
3
Helicobacter pylori infection is an independent risk factor for colonic adenomatous neoplasms.幽门螺杆菌感染是结肠腺瘤性肿瘤的独立危险因素。
Cancer Causes Control. 2017 Feb;28(2):107-115. doi: 10.1007/s10552-016-0839-x. Epub 2016 Dec 27.
4
One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.采用粪便潜血联合检测及远端结肠检查进行一次性结直肠癌筛查。
N Engl J Med. 2001 Aug 23;345(8):555-60. doi: 10.1056/NEJMoa010328.
5
Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia.两种免疫化学法和两种愈创木脂粪便潜血筛查试验用于结直肠肿瘤的性能特征及比较
Dig Dis Sci. 1997 Oct;42(10):2064-71. doi: 10.1023/a:1018866400973.
6
Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.平均风险人群中粪便DNA与粪便潜血用于结直肠癌筛查的比较
N Engl J Med. 2004 Dec 23;351(26):2704-14. doi: 10.1056/NEJMoa033403.
7
Contribution of the OC Sensor immunoassay in comparison to the Hemoccult II guaiac-test in organized colorectal cancer screening.OC 传感器免疫测定与 Hemoccult II 愈创木脂检测在有组织的结直肠癌筛查中的比较。
Eur J Epidemiol. 2019 Feb;34(2):163-172. doi: 10.1007/s10654-018-0471-z. Epub 2018 Dec 8.
8
[Results of coloscopy screening in 2005--an Internet-based documentation].2005年结肠镜检查筛查结果——基于互联网的记录
Dtsch Med Wochenschr. 2006 Feb 24;131(8):379-83. doi: 10.1055/s-2006-932528.
9
Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.用于检测血红蛋白的刷取粪便免疫化学检测法与基于愈创木脂的灵敏粪便潜血检测法在结直肠肿瘤检测中的比较。
Cancer. 2006 Nov 1;107(9):2152-9. doi: 10.1002/cncr.22230.
10

引用本文的文献

1
Effect of rehydration on guaiac-based faecal occult blood testing in colorectal cancer screening.补液对基于愈创木脂的粪便潜血检测在结直肠癌筛查中的影响。
Br J Cancer. 1993 May;67(5):1142-4. doi: 10.1038/bjc.1993.210.
2
Guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening.用于结直肠癌筛查的粪便潜血的愈创木脂法和免疫化学检测
Br J Cancer. 1992 Jun;65(6):942-4. doi: 10.1038/bjc.1992.197.

本文引用的文献

1
Statistical aspects of the analysis of data from retrospective studies of disease.疾病回顾性研究数据的统计分析方面
J Natl Cancer Inst. 1959 Apr;22(4):719-48.
2
Selective screening for colorectal tumors in the Tel-Aviv area: relevance of epidemiology and family history.特拉维夫地区结直肠肿瘤的选择性筛查:流行病学及家族史的相关性
Cancer. 1981 Feb 15;47(4):827-31. doi: 10.1002/1097-0142(19810215)47:4<827::aid-cncr2820470434>3.0.co;2-y.
3
Sensitivity of fecal occult blood testing for adenomas.
Gastroenterology. 1982 Nov;83(5):1136-41.
4
Sensitivity and specificity of the fecal occult blood test for colorectal neoplasia.粪便潜血试验对结直肠肿瘤的敏感性和特异性。
Gastroenterology. 1982 May;82(5 Pt 1):986-91.
5
Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas.结直肠癌或腺瘤患者出血模式与隐血试验敏感性之间的关系。
Gastroenterology. 1982 May;82(5 Pt 1):891-8.
6
Progress report on controlled trial of fecal occult blood testing for the detection of colorectal neoplasia.粪便潜血检测用于结直肠肿瘤检测的对照试验进展报告
Cancer. 1980 Jun 15;45(12):2959-64. doi: 10.1002/1097-0142(19800615)45:12<2959::aid-cncr2820451212>3.0.co;2-e.
7
Immunochemical detection of fecal occult blood--the fecal smear punch-disc test: a new non-invasive screening test for colorectal cancer.粪便潜血的免疫化学检测——粪便涂片打孔盘试验:一种用于结直肠癌的新型非侵入性筛查试验。
Cancer. 1980 Mar 15;45(5 Suppl):1099-102. doi: 10.1002/1097-0142(19800315)45:5+<1099::aid-cncr2820451312>3.0.co;2-t.
8
[Practical experiences with the stool test for occult blood].
Schweiz Med Wochenschr. 1983 Apr 16;113(15):528-34.
9
Current status of fecal occult blood testing in screening for colorectal cancer.
CA Cancer J Clin. 1982 Mar-Apr;32(2):100-12. doi: 10.3322/canjclin.32.2.100.
10
Diagnosis of large-bowel cancer in the asymptomatic patient.
JAMA. 1967 Sep 18;201(12):943-5.